Strikingly, PAK6’s diagnostic efficacy (AUC = 0.93) rivaled that of ProGRP—the current gold-standard SCLC marker (AUC = 0.94)—and surpassed NSE (AUC = 0.89) (Fig. 3A). This evidence concerns the gene ENO2 and small cell lung carcinoma.